Results 251 to 260 of about 101,810 (380)

Implementation and relevance of FAIR data principles in biopharmaceutical R&D.

Drug Discovery Today, 2019
J. Wise, Alexandra Grebe de Barron, A. Splendiani, B. Balali-Mood, Drashtti Vasant, E. Little, Gaspare Mellino, Ian Harrow, Ian Smith, Jan Taubert, K. van Bochove, M. Romacker, P. Walgemoed, R. Jiménez, R. Winnenburg, Tom Plasterer, V. Gupta, Victoria Hedley   +17 more
semanticscholar   +1 more source

Ex Vivo Evaluation of Poly(Solketal Acrylate) Nanoparticles for Intravitreal Drug Delivery to the Posterior Eye Segment

Macromolecular Rapid Communications, EarlyView.
Nile Red‐loaded poly(solketal acrylate) nanoparticles enable fluorescence tracking and exhibit nontoxic profiles in retinal cells. Enhanced cellular uptake and deep retinal penetration after intravitreal injection highlight their excellent potential for targeted ocular drug delivery to the posterior segment of the eye.
Yasaman Pourdakheli Hamedani, José Hurst, Malte Ritter, Philipp Weingarten, Julia Skokowa, Sven Schnichels, Friederike Adams   +6 more
wiley   +1 more source

Prediction of metabolism and solubility of tablet-form drugs according to the biopharmaceutical drug disposition classification system. [PDF]

ADMET DMPK
Pushkarova Y, Zaitseva G, Bouaalam K.
europepmc   +1 more source

Optimal tuning of PID controllers focused on energy efficiency in a multivariable and coupled system. Case study: An AHU in the biopharmaceutical industry

Carlos Alberto García Vázquez, Daniel Tudor Cotfas, Ana Isabel González Santos, Petru Adrian Cotfas, Bernardo Yaser León Ávila, Víctor Pérez Garrido   +5 more
openalex   +1 more source

The cause relation in biopharmaceutical corpora: English and French patterns for knowledge extraction.

, 2002
Elizabeth Marshman
openalex   +1 more source

Biopharmaceutical characterisation of a low‐dose (75 mg) controlled‐release aspirin formulation [PDF]

, 1993
William N. Charman, Susan A. Charman, Donald C. Monkhouse, Steven E. Frisbee, Earle A. Lockhart, Steven J. Weisman, Garret A. FitzGerald   +6 more
openalex   +1 more source

Genetic and Pathological Testing Attitudes for Parkinson's Disease in At‐Risk Relatives

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is increasingly recognized as a neurodegenerative disorder with a broad clinical spectrum and diverse biomarkers enabling early detection. α‐synuclein seed amplification assays (SAA) and genetic testing now allow identification of PD pathology in asymptomatic individuals.
Tal Weil, Anat Mirelman, Roy N. Alcalay, Nurit Omer, Penina Ponger, Avner Thaler   +5 more
wiley   +1 more source

Machine learning driven acceleration of biopharmaceutical formulation development using Excipient Prediction Software (ExPreSo). [PDF]

Comput Struct Biotechnol J
Vidal-Henriquez E, Holder T, Lee NF, Pompe C, Teese MG.   +4 more
europepmc   +1 more source

Cost-Effective and High-Throughput LPS Detection via Microdroplet Technology in Biopharmaceuticals [PDF]

Adriano Colombelli, Daniela Lospinoso, Valentina Arima, Vita Guarino, Alessandra Zizzari, Monica Bianco, Elisabetta Perrone, Luigi Carbone, R. Rella, Maria Grazia Manera   +9 more
openalex   +1 more source

Rare but Relevant? Assessing Variants in Dystonia‐Linked Genes in Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Dystonia and Parkinson's disease (PD) exhibit clinical and genetic overlap, but the relevance of dystonia gene variants in PD remains unclear. Objective The aim was to assess the frequency of dystonia‐linked pathogenic variants in PD.
Lara M. Lange, Zih‐Hua Fang, Laurel Screven, Ai Huey Tan, Roy N. Alcalay, Rim Amouri, Roberta Bovenzi, Matilda Fenn, Joshua L.I. Frost, Joseph Jankovic, Simona Jasaityte, Zane Jaunmuktane, Beomseok Jeon, Ignacio Juan Keller Sarmiento, Rejko Krüger, Gregor Kuhlenbäumer, Chin‐Hsien Lin, Lukas Pavelka, Maria Teresa Periñan, Samia Ben Sassi, Tommaso Schirinzi, Jung Hwan Shin, Joshua M. Shulman, Yi Wen Tay, Ryan Uitti, Tom Warner, Zbigniew K. Wszolek, Lesley Wu, Ruey‐Meei Wu, Kirsten E. Zeuner, Cornelis Blauwendraat, Andrew Singleton, Niccolò E. Mencacci, Huw R. Morris, Shen‐Yang Lim, Katja Lohmann, Christine Klein, the Global Parkinson's Genetics Program (GP2)   +37 more
wiley   +1 more source